藍(lán)紹桓
一、個(gè)人簡(jiǎn)介
藍(lán)紹桓，1980年出生，藥學(xué)系主任，副教授，碩士生導(dǎo)師；入選福建省高層次人才C類；臺(tái)中健康管理學(xué)會(huì)理事； 2019，2021~2023福建省省級(jí)科技特派員；近年發(fā)表SCI論文39篇，第一作者或通訊作者28篇，論文入選ESI熱點(diǎn)文章1篇，高引文章1篇，獲Wiley 2023高下載作者獎(jiǎng)；主持或參與臺(tái)灣科技部項(xiàng)目1項(xiàng)，莆田學(xué)院校級(jí)項(xiàng)目1項(xiàng)；指導(dǎo)創(chuàng)新創(chuàng)業(yè)競(jìng)賽獲省級(jí)獎(jiǎng)項(xiàng)1項(xiàng)，市、校級(jí)5項(xiàng)；國家著作權(quán)1項(xiàng)，2019年莆田學(xué)院科研先進(jìn)個(gè)人；任三十余家SCI期刊審稿人。
教育經(jīng)歷：
2005.9-2018.6中山醫(yī)學(xué)大學(xué)博士醫(yī)學(xué)研究所
2003.9-2005.6亞洲大學(xué)碩士生物科技研究所
1999.9-2003.6中國醫(yī)藥大學(xué)學(xué)士藥學(xué)系
工作經(jīng)歷：
2019.9-至今莆田學(xué)院藥學(xué)與醫(yī)學(xué)技術(shù)學(xué)院副教授
2021.7-至今福建醫(yī)科大學(xué)聯(lián)培碩導(dǎo)副教授
聯(lián)系方式：19906937247，郵箱：shawnlan0713@qq.com
二、科研項(xiàng)目
研究項(xiàng)目
1. “KIAA0101、RAI3 基因于人類肺癌機(jī)制之探討”，臺(tái)灣科技部，2005-2007，參與，80萬
2. “急性細(xì)菌性皮膚和皮膚結(jié)構(gòu)感染藥物功效及安全性研究”，莆田學(xué)院?jiǎn)?dòng)基金，2019-20122，主持，8萬
三、科研成果
論文著作
1. Lan S. H., Lu L. C., Yen Y. Y., Hsieh Y. P., Chen J. C., Wu W. J., Lan S-J, & Lin L. Y.* (2017). Tube feeding among elder in long-term care facilities: A systematic review and meta-analysis. The journal of nutrition, health & aging, 21(1):31-37. (Impact Factor: 4.3, Q1)(T3)
2. Shao-Huan Lan, Li-Chin Lu, Shou-Jen Lan, Jong-Chen Chen, Wen-Jun Wu, Shen-Peng Chang, Long-Yau Lin. (2017). Educational intervention on physical restraint use in long-term care facilities–Systematic review and meta-analysis. The Kaohsiung Journal of Medical Sciences. 33(8):411-421. SCI (Impact Factor: 2.7, Q3) (T4)
3. Ching-Hui Tseng, Li-Chin Lu, Shao-Hwan Lan, Yen-Ping Hsieh, Shou-Jen Lan. (2017). Relationship between emergency care utilization, ambient temperature, and the pollution standard index in Taiwan. International journal of environmental health research, 27(5):1-11. SCI (Impact Factor: 2.2, Q2) (T3)
4. Shao-Huan Lan, Chih-Cheng Lai, Li-Chin Lu, Shen-Peng Chang, Hui-Ting Huang. Efficacy and safety of delafloxacin in the treatment of acute bacterial skin and skin structure infections: a systematic review and meta-analysis of randomized controlled trials. Infection and Drug Resistance, 2019:12 1415–1423. SCI (Impact Factor: 2.9, Q2). (T3)
5. Shao-Huan Lan, Shen-Peng Chang, Chih-Cheng Lai, Li-Chin Lu and Chien-Ming Chao. Ceftaroline efficacy and safety in treatment of complicated skin and soft tissue infection: a systemic review and meta-analysis of randomized controlled trials. Journal of Clinical Medicine, 2019, 8(6):776. SCI (Impact Factor: 3.0, Q1). (T2)
6. Yao-Ming Cheng, Shao-Huan Lan, Yen-Ping Hsieh*, Shou-Jen Lan and Shang-Wei Hsu. Evaluate five different diagnostic tests for dry mouth assessment in geriatric residents in long-term institutions in Taiwan. BMC Oral Health. 2019 19(1):106, SCI (Impact Factor: 2.6, Q2)(T2)
7. Shao-Huan Lan, Shen-Peng Chang, Chih-Cheng Lai, Li-Chin Lu and Chien-Ming Chao. Efficacy and Safety of Ceftaroline for the Treatment of Community-Acquired Pneumonia: A Systemic Review and Meta-Analysis of Randomized Controlled Trials. Journal of Clinical Medicine 2019, 8(6):824, SCI (Impact Factor: 3.0, Q1).(T2)
8. Shao-Huan Lan, Shen-Peng Chang, Chih-Cheng Lai, Li-Chin Lu, Chien-Ming Chao. The efficacy and safety of eravacycline in the treatment of complicated intra-abdominal infections: a systemic review and meta-analysis of randomized controlled trials. Journal of Clinical Medicine 2019, 8(6):866. SCI (Impact Factor: 3.0, Q1).(T2)
9. Shao-Huan Lan, Wei-Ting Lin, Shen-Peng Chang, Li-Chin Lu, Chien-Ming Chao, Chih-Cheng Lai and Jui-Hsiang Wang*. Tedizolid Versus Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infection: A Systematic Review and Meta-Analysis. Antibiotics (Basel) 2019 Sep 4, 8(3). pii: E137; SCI (Impact Factor: 4.3, Q1). (T3)
10. Shao-Huan Lan*, Wei-Ting Lin*, Shen-Peng Chang, Li-Chin Lu, Chih-Cheng Lai, Jui-Hsiang Wang, Chien-Ming Chao. Novel Tetracyclines Versus Alternative Antibiotics for Treating Acute Bacterial Infection: A Meta-Analysis of Randomized Controlled Trials. Antibiotics (Basel). 2019 Nov 22;8(4). pii: E233. (Impact Factor: 4.3, Q1). (T3)
11. Shao-Huan Lan, Shen-Peng Chang, Chih-Cheng Lai, Li-Chin Lu, Chien-Ming Chao. The efficacy and safety of omadacycline in treatment of acute bacterial infection: a systemic review and meta-analysis of randomized controlled trials. Medicine (Baltimore). 2019 Dec;98(51): e18426 (Impact Factor: 1.3, Q3)
12. Li-Chin Lu, Shao-Huan Lan, Yen-Ping Hsieh, Yea-Yin Yen, Jong-Chen Chen, Shou-Jen Lan. Horticultural Therapy in Patients with dementia: A Systematic Review and Meta-Analysis. American Journal of Alzheimer's Disease & Other Dementias. 2020 Jan; 35: 1533317519883498 (Impact Factor: 2.7, Q2) (T4)
13. Shu-Ya Yang, Shou-Jen Lan, Yea-Yin Yen, Yen-Ping Hsieh, Pei-Tseng Kung, Shao-Huan Lan*. Effects of Exercise on Sleep Quality in Pregnant Women: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Asian Nursing Research (Korean Soc Nurs Sci). 2020 Jan 29. 14(1): 1-10. (Impact Factor: 2.1, Q2) (T2)
14. Lan, Shao-Huan; Chang, Shen-Peng; Lai, Chih-Cheng; Lu, Li-Chin; Tang, Hung-Jen*. Efficacy and safety of cefoperazone-sulbactam in empiric therapy for febrile neutropenia: A systemic review and meta-analysis. Medicine (Baltimore). 2020 Feb;99(8): e19321. (Impact Factor: 1.3, Q3) (T4)
15. Li-Chin Lu, Chih-Cheng Lai, Shen-Peng Chang, Shao-Huan Lan, Shun-Hsing Hung, Wei-Ting Lin*. Novel β-Lactam/β-Lactamase Inhibitor Combinations v.s. Alternative Antibiotics in the Treatment of Complicated Urinary Tract Infections: A Meta-Analysis of Randomized Controlled Trials. Medicine (Baltimore). 2020 May; 99(19): e19960 (Impact Factor: 1.3, Q3)
16. Li-Chin Lu, Shao-Huan Lan, Yen-Ping Hsieh, Long-Yau Lin, Jong-Chen Chen, Shou-Jen Lan. Massage therapy for weight gain in preterm neonates: A systematic review and meta-analysis of randomized controlled trials. Complementary Therapies in Clinical Practice. 2020 May; 39:101168. (Impact Factor: 2.2, Q2) (T2)
17. Ching-Chu Liao, Shao-Huan Lan, Yea-Yin Yen, Yen-Ping Hsieh, Shou-Jen Lan. Aromatherapy intervention on anxiety and pain during first stage labour in nulliparous women: a systematic review and meta-analysis. Journal Obstetrics and Gynecology. 2020 Jul 15:1-11. (Impact Factor:1.226, Q4) (T4)
18. Shao-Huan Lan, Chih-Cheng Lai, Hui-Ting Huang, Shen-Peng Chang, Li-Chin Lu, Po-Ren Hsueh. Tocilizumab for severe COVID-19: a systematic review and meta-analysis. International Journal of Antimicrobial Agents. 2020 Jul 23:106103. (Impact Factor: 4.9, Q1)- (7/279, 2.3%) (T2)
19. Shao?Huan Lan, Chih?Cheng Lai, Shen?Peng Chang, Li?Chin Lu, Shun?Hsing Hung* &
Wei?Ting Lin. Vitamin D and outcomes in adult critically ill patients. A systematic review and meta-analysis of randomized trials. Scientific Reports. (2020) 10:14261. (Impact Factor: 3.8, Q1) (T3)
20. Shao?Huan Lan, Chih?Cheng Lai, Shen?Peng Chang, Li?Chin Lu, Shun?Hsing Hung* & Wei?Ting Lin. Five-Day Antibiotic Treatment for Community-Acquired Bacterial Pneumonia A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Journal of Global Antimicrobial Resistance. 2020 Aug 28;23:94-99. (Impact Factor: 3.7, Q2) (T3)
21. Shao-Huan Lan, Chih-Cheng Lai, Shen-Peng Chang, Chun-Chun Hsu, Cheng-Hsin Chen, Ya-Hui Wang, Yueh Lan Huang, Cheng-Yi Wang, You-Shuei Lin. Efficacy and safety of anti-interleukin-5 therapy in patients with chronic obstructive pulmonary disease: a meta-analysis of randomized, controlled trials. Journal of Microbiology, Immunology and Infection. 2022 Feb;55(1):26-35 (Impact Factor: 4.5, Q1)- (T2)
22. Shao-Huan Lan, Chien-Ming Chao, Shen-Peng Chang, Li-Chin Lu, Chih-Cheng Lai. Efficacy and Safety of Cefoperazone-Sulbactam in Treatment of Intra-Abdominal Infections: A Systematic Review and Meta-Analysis. Surg Infect (Larchmt). 2021 Oct;22(8):763-770 (Impact Factor: 1.4, Q3)(T4)
23.Shao-Huan Lan, Hong-Zin Lee, Chih-Cheng Lai, Shen-Peng Chang, Li-Chin Lu, Shun-Hsing Hung, Wei-Ting Lin. Clinical Efficacy and Safety of Ceftobiprole in the Treatment of Acute Bacterial Skin and Skin Structure Infection: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Expert Review of Anti-Infective Therapy. 2021 Jun 15;1-8 (Impact Factor: 4.2, Q1) (T2)
24. Li-Chin Lu, Shao-Huan Lan, Yen-Ping Hsieh, Shou-Jen Lan. Effectiveness of intergenerational participation on residents with dementia: A systematic review and meta-analysis. Nursing Open. 2022 Mar;9(2):920-931. (Impact Factor: 2.0, Q2). (T4)
25. Li-Chin Lu, Shao-Huan Lan, Yen-Ping Hsieh, Long-Yau Lin, Shou-Jen Lan, Jong-Chen Chen. Effectiveness of Companion Robot Care for Dementia: A Systematic Review and Meta-Analysis. Innovation in Aging. 2021 Apr 24;5(2): igab013. (Impact Factor:4.9, Q1) (T3)
26. Li-Chin Lu, Fei-Yu Chang, Guo-Zhong Lv*, Shao-Huan Lan*. Effectiveness and Safety of Compound Polymyxin B Ointment in Treatment of Burn Wounds: A Meta-analysis. Journal of Burn Care & Research. 2022 Mar 23;43(2):453-461.(Impact Factor: 1.5, Q3)(T4)
27. Shao-Huan Lan, Chiung-Kai Wang, Shen-Peng Chang, Li-Chin Lu, Shun-Hsing Hung, Wei-Ting Lin. Janus Kinase Inhibitors for Hospitalized Patients With COVID-19: A Meta-Analysis of Randomized Controlled Trials. Expert Review of Anti-infective Therapy. 2022 May;20(5):773-779. (Impact Factor: 4.2, Q1) (T2)
28. Shao-Huan Lan, Hong-Zin Lee, Chien-Ming Chao, Shen-Peng Chang, Li-Chin Lu, Chih-Cheng Lai. Efficacy of Melatonin in the Treatment of Patients With COVID-19: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Journal of Medical Virology. 2022 May;94(5):2102-2107 (Impact Factor: 6.8, Q1) (T3)
29. Huamei Zhuang, Chih-Cheng Lai, Shao-Huan Lan, Shen-Peng Chang, Li-Chin Lu, Shun-Hsing Hung, Wei-Ting Lin. Novel β-Lactam/β-Lactamase Inhibitor Combinations versus Alternative Antibiotics in Adults with Hospital-Acquired Pneumonia or Ventilator-Associated Pneumonia: An Integrated Analysis of 3 Randomized Controlled Trials. Journal of Global Antimicrobial Resistance. Volume 29, June 2022, Pages 398-404 (Impact Factor: 3.7, Q2) (T3)
30. Shao-Huan Lan, Chih-Cheng Lai, Shen-Peng Chang, Li-Chin Lu, Shun-Hsing Hung, Wei-Ting Lin. Favipiravir-based treatment for outcomes of patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials. Expert Review of Clinical Pharmacology. 2022 Jun;15(6):759-766. (Impact Factor: 3.6, Q2) (T3)
31. Shao-Huan Lan, Chih-Cheng Lai, Shen-Peng Chang, Li-Chin Lu, Shun-Hsing Hung. Accelerated-strategy renal replacement therapy for critically ill patients: a systematic review and meta-analysis. Medicine.2022 Jul 8; 101(27): e29747. (Impact Factor: 1.3, Q3)
32. Shao-Huan Lan,Shun-Hsing Hung, Shen-Peng Chang, Li-Chin Lu, Chih-Cheng Lai &Wei-Ting Lin. Pro-, pre- and synbiotics for the prevention of incidental ventilator-associated pneumonia among critically ill patients: a systematic review and meta-analysis of randomized controlled trials. Expert Review of Anti-infective Therapy. 2022 Sep;20(9):1205-1215. (Impact Factor: 4.2, Q1) (T2)
33. Shao-Huan Lan, Chih-Cheng Lai, Shen-Peng Chang, Li-Chin Lu, Shun-Hsing Hung, Wei-Ting Lin. Effect of colchicine on the outcomes of patients with COVID-19: A systematic review and meta-analysis of randomized controlled trials. Annals of Medicine. 2022; 54(1): 1956–1965. (Impact Factor: 4.9, Q1) (T2)
34. Shao-Huan Lan, Chien-Ming Chao, Shen-Peng Chang, Li-Chin Lu, Tzu-Liang Hsu. Iclaprim Versus Vancomycin for the Treatment of Acute Bacterial Skin and Skin Structure Infection: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Ulutas Medical Journal. 2022:8(3):100-109
35. Li-Chin Lu; Chien-Ming Chao; Shen-Peng Chang; Shao-Huan Lan; Chih-Cheng Lai. Clinical efficacy and safety of topical difamilast in the treatment of patients with atopic dermatitis: a systematic review and meta-analysis of randomized controlled trials. Expert Review of Clinical Pharmacology. Accepted. (Impact Factor: 3.6, Q2) (T3)
36. Li-Chin Lu; Chien-Ming Chao; Shen-Peng Chang; Shao-Huan Lan; Chih-Cheng Lai. Effect of Fluvoxamine on Outcomes of Nonhospitalized Patients with COVID-19: A Systematic Review and Meta-analysis. Journal of Infection and Public Health. 2022 Nov; 15(11): 1259–1264. (Impact Factor: 4.7, Q1) (T3)
37. Shao-Huan Lan, Chih-Cheng Lai, Shen-Peng Chang, Li-Chin Lu, Shun-Hsing Hung, Wei-Ting Lin. Clinical efficacy and safety of interleukin-1 blockade in the treatment of patients with COVID-19: A systematic review and meta-analysis of randomized controlled trials. Annals of Medicine. 2023 Dec;55(1):2208872. doi: 10.1080/07853890.2023.2208872. (Impact Factor: 4.9, Q1) (T2)
38.Gui-Lin Ran, Yan-Ping Li, Li-Chin Lu, Shao-Huan Lan*. Disease-modifying therapies for diabetic peripheral neuropathy: A systematic review and meta-analysis of randomized controlled trials. Journal of Diabetes and its Complications. 2024 Feb;38(2):108691.(Impact Factor: 2.9, Q3)(T3)
39.Gui-Lin Ran, Yan-Ping Li, Li-Chin Lu, Shao-Huan Lan*. Phosphodiesterase 4 Inhibitor Use in Pediatric Patients With Atopic Dermatitis: A Meta-Analysis of Randomized Controlled Trials. Advances in Skin & Wound Care. (Revised)
40. Li-Chin Lu, Shao-Huan Lan, Shou-Jen Lan, Yen-Ping Hsieh. Effectiveness of the Music Therapy in Dementia: A Systematic Review andMeta-Analysis of Randomized Controlled Trials. Dementia and Geriatric Cognitive Disorders. (Revised)
知識(shí)產(chǎn)權(quán)
1. 林偉鴻、柳毅冰、盧麗伈、藍(lán)紹桓. 青農(nóng)培育學(xué)堂系統(tǒng). 第10330305號(hào). 2022.09.27.（軟件著作權(quán)，授權(quán)）。
四、其他
獲獎(jiǎng)成果
1.“Tocilizumab for severe COVID-19: a systematic review and meta-analysis”獲2021年度ESI Hot paper (top 0.1% of papers in the academic fieldof “Pharmacology & Toxicology”)。
2.“Tocilizumab for severe COVID-19: a systematic review and meta-analysis”獲2021~2024年度ESI Highly cited paper (top 1% oftheacademic field of “Pharmacology & Toxicology”)。
3. 獲2023年度Wiley 高下載作者獎(jiǎng)。
